StaniPharm is a Contract Development and Manufacturing Organization (CDMO). Pioneers in supercritical CO2 technologies, we operate a state-of-the-art facility and provide the life science industry with flexible development and GMP manufacturing services. We move your products from idea to market: botanical extracts, challenging polymers and lipids, nanomedicines, tailored drug particles. Keywords : nanoparticles, medicinal cannabis, particle and crystal engineering, crystallization, polymers, lipids, supercritical fluids, purification, formulation, impregnation, sterilization, GMP manufacturing, poorly soluble drugs, polymorphism, CDMO
Looking for a particular STANIPHARM employee's phone or email?
The STANIPHARM annual revenue was $2 million in 2026.
Frantz Deschamps is the President of STANIPHARM.
12 people are employed at STANIPHARM.
STANIPHARM is based in Champigneulles, Grand-Est.
The NAICS codes for STANIPHARM are [32, 325, 3254, 32541].
The SIC codes for STANIPHARM are [283, 28].